Astellas Logo PNG
The Astellas logo emphasizes the company’s rigorous and professional approach to pharmaceuticals and innovation. It conveys precision, accuracy, and confidence in scientific advancements that support people’s health and well-being.
Astellas Pharma grew from two Japanese drugmakers. Tomokichi Fujisawa founded Fujisawa Pharmaceutical in Osaka in 1894. Its defining product became tacrolimus, an immunosuppressant isolated from a soil bacterium and sold as Prograf. The medicine reduced organ rejection and became the company’s main revenue source during the 1990s and early 2000s.
Yamanouchi Pharmaceutical was founded in Tokyo in 1923 and concentrated on gastrointestinal and urological treatments. During the 1980s, it marketed Gastrozepin and H2-receptor antagonists for ulcers. In the 1990s, it developed tamsulosin for benign prostatic hyperplasia. Sold internationally as Harnal, the drug supported expansion into Europe and the United States.
Fujisawa and Yamanouchi merged in April 2005 as Astellas Pharma, responding to consolidation among Pfizer, Novartis, and AstraZeneca. The name drew on the Latin word “stella,” meaning star. Headquartered in Tokyo, it entered the global top 20 by revenue. In 2010, it bought OSI Pharmaceuticals for $4 billion, adding the cancer drug Tarceva and entering oncology alongside Roche and AstraZeneca.
Later purchases moved Astellas into research fields. Agensys added antibody work in 2016. Audentes Therapeutics, acquired for $3 billion in 2019, brought a gene-therapy platform for rare neuromuscular diseases, while Xyphos Biosciences added CAR-T technology. In 2023, the $5.9 billion purchase of Iveric Bio added a treatment program for geographic atrophy of the retina.
Meaning and History
What is Astellas?
The merger of two companies formed a major Japanese pharmaceutical manufacturer. It specializes in treatments for urology, organ transplantation, cancer, and immune disorders. Its drugs hold leading positions in the treatment of prostate cancer. Special attention is paid to cell technologies, regenerative medicine, and stem cell research.
2005 – today
The updated Astellas logo is built around a bright, star-shaped motif formed by two intersecting curved lines. Each is asymmetrical, elongated, and oriented differently, resembling a stylized initial A from the brand name.
The color scheme is based on the contrast of red and gray tones. Red conveys strength, energy, and the brand’s bold position in medical research. Gray is associated with precision, rationality, and the high expertise required in pharmaceuticals. Their overlap in the central area creates a zone of deep saturated color that adds expressiveness and volume to the graphic.
The company name is placed to the right of the star symbol. The typeface is thin and classic with delicate serifs and balanced proportions. All letters are lowercase, which adds openness and a modern, light feel to the inscription. The elegant type looks professional and understated.
The star symbol conveys Astellas’ aspiration toward excellence and high standards in medical technology. The entire composition takes on an elegant, technological character, highlighting the brand’s innovative spirit and authority within the professional community.
